Paramount Cosmetic Peer Comparison

BSE: 507970

₹37.00

₹0.37 (1.01%)

As on 23-Sep-2026IST

Market cap

₹18 Cr

Revenue (TTM)

₹20 Cr

P/E Ratio

81.3

P/B Ratio

0.9

Div. Yield

0 %

Edit

	Paramount Cosmetic	Recode Studios	Cupid	Gillette India	Zydus Wellness
Market cap (₹ Cr)	18	444	36,723	23,095	16,861
Revenue (₹ Cr)	20	48	455	3,176	4,537
Net Profit (₹ Cr)	0.22	3.30	137.38	668.07	188.20
Net Margin (%)	1.03	6.89	28.40	20.86	4.14
RoE (%)	1.08	46.37	33.02	63.35	3.99
Price to Earnings	81.28	39.52	267.32	34.57	89.59
Price-To-Book	0.87	7.86	74.25	21.18	2.84

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Paramount Cosmetic	Recode Studios	Cupid	Gillette India	Zydus Wellness
Operating Revenue	20.38	47.80	183.52	2,633.08	2,708.90
Total Income	21.61	47.94	203.18	2,659.18	2,723.30
Total Expenditure	19.40	41.61	141.80	2,001.68	2,330.00
EBITDA	0.98	6.19	41.73	631.40	378.90
Depreciation	0.55	0.64	4.48	82.64	28.40
EBIT	0.44	5.54	37.25	548.76	350.50
Interest	1.60	1.25	2.05	12.61	12.00
Other Income	1.23	0.14	19.66	26.10	14.40
Exceptional Items	--	--	--	--	5.90
Profit before Tax	0.07	4.43	54.86	562.25	358.80
Provision for Tax	0.04	1.13	13.97	150.55	11.90
Profit after Tax	0.03	3.30	40.89	411.70	346.90

Liabilities (₹ Cr)

	Paramount Cosmetic	Recode Studios	Cupid	Gillette India	Zydus Wellness
Shareholder's Funds	20.37	8.77	342.19	971.27	5,671.60
Minority Interest	--	--	--	--	--
Non-Current Liabilities	3.85	2.56	8.39	46.97	-119.90
Current Liabilities	15.83	11.61	21.20	759.04	745.50
Total Liabilities	40.48	23.18	371.78	1,830.75	6,441.90

Assets (₹ Cr)

	Paramount Cosmetic	Recode Studios	Cupid	Gillette India	Zydus Wellness
Non-Current Assets	14.25	2.61	89.90	590.67	5,193.00
Current Assets	25.79	20.33	281.88	1,186.61	1,104.20
Total Assets	40.48	23.18	371.78	1,830.75	6,441.90
Total Debt*	11.39	7.56	12.63	0.00	185.00
Net Current Assets	9.96	8.72	260.68	427.57	358.70
Contingent Liabilities	0.80	--	6.37	1,408.05	351.30

Cashflow (₹ Cr)

	Paramount Cosmetic	Recode Studios	Cupid	Gillette India	Zydus Wellness
Cash From Operating Activities	1.40	3.14	-11.14	509.04	380.00
Cash Flow from Investing Activities	0.96	-1.00	44.68	-49.15	-223.60
Cash from Financing Activities	-2.41	-1.48	-1.47	-439.90	-186.30
Net Cash Inflow / Outflow	-0.05	0.66	32.08	19.99	-29.90

Ratios

Profitability Ratios

	Paramount Cosmetic	Recode Studios	Cupid	Gillette India	Zydus Wellness
ROCE (%)	5.18	38.34	17.04	58.66	6.43
ROE (%)	0.15	46.37	18.25	42.92	6.29
ROA (%)	0.07	16.71	11.82	22.57	5.65
EBIT Margin (%)	10.87	13.23	33.45	24.97	14.52
Net Margin (%)	0.14	6.89	20.12	15.48	12.74
Cash Profit Margin (%)	2.85	7.83	24.72	15.42	12.78

Growth Ratios

	Paramount Cosmetic	Recode Studios	Cupid	Gillette India	Zydus Wellness
Revenue Growth (%)	-6.54	29.82	6.88	6.30	16.37
EBIT Growth (%)	-11.65	245.53	7.10	17.13	22.10
Net Profit Growth (%)	40.19	1,104.12	2.59	15.75	29.97
EPS Growth (%)	40.14	1,104.15	925.59	15.75	29.97
Book Value Growth (%)	0.26	60.36	19.40	-2.18	5.86

Valuation Ratios

	Paramount Cosmetic	Recode Studios	Cupid	Gillette India	Zydus Wellness
Price / Earnings	647.25	0.00	8.32	57.34	6.13
Price / Book Value	0.95	0.00	6.97	24.88	1.87
Dividend Yield (%)	0.00	--	0.00	1.79	0.36
EV/EBITDA	13.25	1.07	26.79	35.18	27.31
Market Cap (₹ Cr)	19.42	0.00	1,700.47	23,607.67	10,631.08

Solvency Ratios

	Paramount Cosmetic	Recode Studios	Cupid	Gillette India	Zydus Wellness
Debt to Equity	0.56	0.86	0.05	0.00	0.03
Short term debt to equity ratio	0.34	0.32	0.04	--	0.03
Current Ratio	1.63	1.75	13.30	1.56	1.48
Quick Ratio	0.29	0.97	11.33	1.04	0.79
Interest Coverage	1.04	4.55	27.74	45.59	30.90

Operating Efficiency Ratios

	Paramount Cosmetic	Recode Studios	Cupid	Gillette India	Zydus Wellness
Debtors to sales (%)	10.64	16.92	36.53	10.42	13.55
Asset Turnover	0.51	2.55	0.53	1.76	0.48
Receivable days	54.03	50.84	114.37	33.84	40.43
Inventory Days	342.02	57.22	57.01	46.00	61.24
Payable days	54.48	52.78	6.27	218.60	113.05
Cash Conversion Cycle	341.58	55.28	165.11	-138.76	-11.38

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.